ARIA: holding through Ridaforolimus ASCO and re-evaluate; I want to still be long the stock through Ponatinib news I just think ASCO tops this stock for 6 months
ONTY: holding through Stimuvax Phase 3; IMO, if Stimuvax is a success this company is severely undervalued. Doesn't get anymore binary than this POS.
IMUC: so far off, I will likely sell on any news pop - they're not going to be done with a Phase 3 for at least 3 - 5 years - basically, it's a long-term hold or short term pop and sell.
CRIS: holding through GDC_0449 June news, and then re-evaluate. I didn't get the pop I wanted on BCC news, so I'm waiting on what ASCO brings in solid tumors (pancreatic and lung) for GDC_0449. Later in June, are final BCC results to be presented.
The above is all my own strategies. Wish I could time this trash better....but, it's biotech, and you never know what's a day away.
